Toine van der Heijden

12PUBLICATIONS
77CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Exercise physiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.

|Apr 01, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Roberto Contieri, Paolo Gontero, Rodolfo Hurle

|Jun 30, 2025
Physical activity and risks of recurrence and progression among patients with non-muscle invasive bladder cancer.

Ivy Beeren, Joann Kiebach, Jasper P Hof

|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali

|Mar 28, 2025
Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer.

Meritxell Pérez, Juan José Lozano, Mercedes Ingelmo-Torres

|Jan 26, 2025
Fluid intake and recurrence and progression risk of patients with non-muscle-invasive bladder cancer.

Ivy Beeren, Hilde Meijer, Antoine G van der Heijden

Pageof 2

Frequent Collaborators

3 joint publications

Niven Mehra

3 joint publications

Alina Vrieling

3 joint publications

Laura S Mertens

3 joint publications

Lambertus A L M Kiemeney